1147080 Webinar Banner 2.png
novartis_rm_logo_pos_rgb.png

Ocular Gene Therapy 
IRD treatment and the development of ocular gene therapy
25th November 2021 | 19:00 – 20:00 GMT

The meeting is organised and funded by Novartis Pharmaceuticals UK

UK | November 2021 | 168396